YOU ARE HERE: LAT HomeCollectionsInsulin


September 24, 1986 | MARCIDA DODSON, Times Staff Writer
In the first trial studies of their kind in the United States, diabetes specialists from UC Irvine and Johns Hopkins University have been given approval by the U.S. Food and Drug Administration to surgically implant insulin pumps, UCI officials said Tuesday.
June 22, 2011 | By Marissa Cevallos, HealthKey / For the Booster Shots blog
Supreme Court Justice Sonia Sotomayor spoke out this week about her Type 1 diabetes, calling attention to the issue—a condition that as many as 3 million Americans know well. The pinpricks for blood, the glucose monitors, the insulin injections… Daily life isn’t easy, the Supreme Court justice told a gathering of children with diabetes. An online diabetic community would seem to agree. This from the blog Cure Moll : “When I was 10, my mom and I were used to shots, we knew the perfect amount of insulin for everything, from a small piece of pizza and cake at a birthday party to simply cereal for breakfast.
August 20, 1990 | Compiled from Times staff and wire reports
An experimental transplant operation designed to free diabetics from insulin injections has produced the most promising results since the technique was developed, researchers reported last week. The procedure enabled five of nine patients to significantly reduce their need for daily insulin injections, including one 16-year-old Louisville, Ky., girl who has remained completely independent of injections for more than six months, the researchers reported. "I'm completely excited," said Dr.
November 1, 2010 | By Amanda Leigh Mascarelli, Special to the Los Angeles Times
Every night, Edward Damiano wakes three to four times to monitor his 11-year-old son's blood sugar levels. Damiano administers insulin remotely through a pump when his son's blood sugar reading is high or gives him juice through a straw when his blood sugar falls. His son, David, who was diagnosed with Type 1 diabetes at 11 months old, sleeps peacefully through it all ? and that's exactly what worries Damiano. "You can check his blood sugar all night long and he won't wake up," Damiano says.
June 6, 2011 | By Thomas H. Maugh II, Los Angeles Times
Physicist Rosalyn S. Yalow, who shared the 1977 Nobel Prize in Physiology or Medicine for the development of a medical diagnostic test that revolutionized patient care and led to a new understanding of diabetes and a host of other diseases, died May 30 in the Bronx, N.Y. She was 89. No cause of death was announced. Although her work in medical diagnostics was seminal, she was perhaps equally well known for her temerity in entering a field that had previously been dominated by men and for her persistence in pursuing her goals in the face of opposition from the establishment and the opposite sex. She was only the second woman to win the Nobel in medicine and only the sixth to win a Nobel in any science.
December 1, 2011 | By Eryn Brown, Los Angeles Times / For the Booster Shots blog
On Thursday the Food and Drug Administration issued draft guidelines for researchers and manufacturers working to develop and build an artificial pancreas to help patients with Type 1 diabetes control their blood sugar. About 3 million Americans have Type 1 diabetes, which develops when cells in the pancreas stop producing enough insulin to control blood sugar.  Patients with the disease must monitor their blood glucose aggressively.  If it goes too high, they have to carefully calculate how much insulin they need to bring it in line -- and then get an injection.  If a person with Type 1 diabetes' blood sugar drops too low, he or she could require a dose of another hormone, glucagon, to raise it back up. The unrelenting and error-prone process can be exhausting, so patient advocacy groups such as the Juvenile Diabetes Research Foundation have been pushing the development of an artificial pancreas that would tightly control blood sugar levels much as the actual organ: monitoring glucose levels continually and automatically delivering the right dose of insulin, through a pump, into the body.  The system would work by connecting the monitoring system to a computer, which in turn would calculate the correct insulin dose and send a signal to the insulin pump to deliver the needed hormones.
Scientists have delayed the onset of full-blown Type 1 diabetes in young people for at least a year with a two-week drug treatment that blocked a specific part of the youths' immune systems. Patients taking the drug continued to produce their own insulin and required fewer and smaller insulin shots than those who were not treated, according to a study published today in the New England Journal of Medicine.
February 23, 2008 | From Times Staff and Wire Reports
Human embryonic stem cells transformed into nearly normal insulin-producing cells when implanted into mice, possibly offering a way to treat diabetes long-term, according to research published online in the journal Nature Biotechnology. A team from Novocell Inc. in San Diego used embryos discarded by fertility clinics, implanting immature cells under the skin and into other areas of the mice. For reasons that are not completely understood, chemicals in the animal's body directed them to begin producing insulin and other enzymes normally produced by pancreatic islets.
Los Angeles Times Articles